HRGN — Harvard Apparatus Regenerative Technology Balance Sheet
0.000.00%
- $31.33m
- $30.61m
- $0.43m
Annual balance sheet for Harvard Apparatus Regenerative Technology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.03 | 1.24 | 1.24 | 0.432 | 2.49 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.077 | 0 | — | 0.004 | 0.231 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.68 | 1.59 | 1.59 | 0.783 | 3.23 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.399 | 0.279 | 0.196 | 0.073 | 0.304 |
| Other Long Term Assets | |||||
| Total Assets | 2.08 | 1.87 | 2.4 | 2.61 | 4.44 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.756 | 4.84 | 1.36 | 0.968 | 1.02 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.951 | 4.89 | 1.41 | 0.968 | 1.22 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.13 | -3.03 | 0.989 | 1.65 | 3.22 |
| Total Liabilities & Shareholders' Equity | 2.08 | 1.87 | 2.4 | 2.61 | 4.44 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |